A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia.

Cappellini MD; Viprakasit V; Taher AT; Georgiev P; Kuo KHM; Coates T; Voskaridou E; Liew HK; Pazgal-Kobrowski I; Forni GL

doi:10.1056/nejmoa1910182

A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia.

Identifier:nobleid.org/w1/20260526/F71BC5F3

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/F71BC5F3.svg?ark=w1%2F20260526%2FF71BC5F3)](https://nobleid.org/work/w1/20260526/F71BC5F3)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia.

Identifier:nobleid.org/w1/20260526/F71BC5F3

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/F71BC5F3.svg?ark=w1%2F20260526%2FF71BC5F3)](https://nobleid.org/work/w1/20260526/F71BC5F3)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work